-transparent.png){kind=logo}
Substance "P" (SP) and its derivatives inhibited activity of angiotensin-converting enzyme (ACE) in human blood serum, I50 for SP was 31 microM. The same results were obtained for N-terminal fragments of the SP molecule: Arg-Pro-Lys-Pro and Lys-Pro. The C-terminal heptapeptide and the dipeptide Arg-Pro negligibly inhibited ACE activity. A possible significance of the interaction between SP and ACE in the regulation of the microhemodynamics is discussed.
Related Publications
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
January 1988,
European journal of clinical pharmacology,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
September 1979,
Neuroscience letters,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
December 1982,
European journal of pharmacology,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
January 1989,
Neuropeptides,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
March 1987,
Die Pharmazie,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
May 2014,
Hypertension (Dallas, Tex. : 1979),
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
November 2004,
Klinicheskaia laboratornaia diagnostika,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
February 1977,
The Tohoku journal of experimental medicine,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
July 1983,
Journal of clinical pathology,
N V Komissarova, and
W E Siems, and
O A Gomazkov, and
P Oehme, and
K D Jentzsch
February 1996,
Thorax,
